Related Experiment Video
Updated: Jul 26, 2025

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
Published on: July 18, 2016
Health Disparities in Ovarian Cancer: Report From the Ovarian Cancer Evidence Review Conference
Shirley Mei1, David Chelmow, Kimberly Gecsi
1Departments of Obstetrics and Gynecology, New York University Langone School of Medicine, New York, New York, Virginia Commonwealth University School of Medicine, Richmond, Virginia, the Medical College of Wisconsin, Milwaukee, Wisconsin, Creighton University School of Medicine, Phoenix, Arizona, the University of California, Davis, Davis, California, the University of Iowa Hospitals and Clinics, Ames, Iowa, and Stony Brook University Hospital, New York, New York; and the American College of Obstetricians and Gynecologists, Washington, DC.
Health disparities significantly impact ovarian cancer outcomes, affecting survival and diagnosis stages based on race, insurance, and location. Adhering to National Comprehensive Cancer Network guidelines may help reduce these inequities.
Area of Science:
- Oncology
- Public Health
- Health Disparities Research
Background:
- Health disparities, defined by the Centers for Disease Control and Prevention (CDC), represent preventable differences in health outcomes for socially disadvantaged populations.
- These disparities are evident across numerous diseases, including gynecologic cancers.
- This review specifically addresses ovarian cancer disparities as part of a CDC-sponsored initiative.
Approach:
- Conducted an evidence review focusing on health disparities, inequities, and mitigation strategies in ovarian cancer.
- The review aimed to inform the development of educational materials for clinicians on gynecologic cancer prevention and early diagnosis.
Key Points:
- Profound disparities in ovarian cancer outcomes were identified, including survival rates, treatment access, and stage at diagnosis.
- These disparities correlate with factors such as race and ethnicity, insurance status, socioeconomic status, and geographic location.
- Limited direct evidence was found regarding effective mitigation strategies for these disparities.
Conclusions:
- While direct evidence on mitigation is scarce, studies indicate that equivalent response to equivalent treatment exists across different demographic groups.
- Adherence to National Comprehensive Cancer Network (NCCN) guidelines shows potential to partially mitigate observed differences in ovarian cancer outcomes.
- Further research and targeted interventions are needed to address and reduce ovarian cancer health inequities.
Related Concept Videos
Treatment Resistant Cancers
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Bias in Epidemiological Studies
Oogenesis
Cancer Prevention
Some...
Cancer Survival Analysis

